Correlation of KIT and PDGFRA mutational status with clinical benefit in patients (pts) with gastrointestinal stromal tumor (GIST) treated with sunitinib (SU) in a worldwide treatment-use (TU) trial

Abstract

Experimentele farmacotherapi

    Similar works

    Full text

    thumbnail-image